News and notices. January 05, 2015
5 key reasons anti-VEGF treatment for acute ROP is NOT yet recommended
Clare Gilbert, global expert on childhood blindness and co-director of the International Centre for Eye Health, London School of Hygiene and Tropical Medicine, explains why anti-VEGF agents are not recommended for acute, severe retinopathy of prematurity (ROP).